Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Philippe Moreau(Centre National de la Recherche Scientifique), Jean‐Luc Harousseau(Hospital de Santa Maria), Rafaël Fonseca(Mayo Clinic in Arizona), P. Leif Bergsagel(Mayo Clinic in Arizona), Enrique M. Ocio(Universidad de Salamanca), Dominik Dytfeld, Hermann Einsele(Universitätsklinikum Würzburg), Surbhi Sidana(Palo Alto University), Christoph Driessen(University of Zurich), Jesús F. San Miguel(Clinica Universidad de Navarra), Cristina João(Universidade Nova de Lisboa), Katja Weisel(Universität Hamburg), Sagar Lonial(Emory University), Ângelo Maiolino(Universidade Federal do Rio de Janeiro), Thierry Façon(Université de Lille), Brian G.M. Durie(Cedars-Sinai Medical Center), Shaji Kumar(Mayo Clinic), Heinz Ludwig(Wilhelminen Hospital), Suzanne Lentzsch(Columbia University Irving Medical Center), Joan Bladé(Hospital Clínic de Barcelona), Kenneth C. Anderson(Dana-Farber Cancer Institute), Niels W.C.J. van de Donk(Oncode Institute), Faith E. Davies(NYU Langone Health), Evangelos Terpos(National and Kapodistrian University of Athens), Ulf‐Henrik Mellqvist, Artur Jurczyszyn(Jagiellonian University), Xavier Leleu(Inserm), Jesús G. Berdeja(Tennessee Oncology), Anders Waage(St Olav's University Hospital), Noopur Raje(Massachusetts General Hospital), Elena Zamagni(Istituti di Ricovero e Cura a Carattere Scientifico), Joseph Mıkhael(Translational Genomics Research Institute), Thomas G. Martin(University of California San Francisco Medical Center), Monika Engelhardt(University Medical Center Freiburg), Nizar J. Bahlis(Institute of Cancer Research), Wee Joo Chng(National University of Singapore), Kwee Yong(CRUK Lung Cancer Centre of Excellence), Annette Juul Vangsted(Copenhagen University Hospital), Michèle Cavo(Unknown), Rachid Baz(Moffitt Cancer Center), Fredrik Schjesvold(Oslo University Hospital), Eloísa Riva(Hospital de Clínicas), Roman Hájek(University Hospital Ostrava), Hang Quach(The University of Melbourne), Vânia Hungria(Faculdade de Ciências Médicas da Santa Casa de São Paulo), Fernando Leal da Costa(University of Alabama at Birmingham), Jian Hou, Sigurður Y. Kristinsson(Reykjavík University), David H. Vesole(Hackensack University Medical Center), Pieter Sonneveld(Erasmus MC Cancer Institute)
Cited by 266
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k